The possession, sale, manufacture, deliver, or transport of the following chemicals is prohibited in Owingsville, Kentucky:
(A) Tetrahydrocannabinols - synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, immediate derivatives and their isomers with similar chemical structure and pharmacological activity such as the following:
(1) Delta-1 Cis or trans tetrahydrocannabinol, and their optical isomers;
(2) Delta-6 Cis or trans tetrahydrocannabinol, and their optical isomers;
(3) Delta-3,4 Cis or trans tetrahydrocannabinol, and its optical isomers;
(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, is covered.)
(B) Synthetic cannabinoids as follows:
(1) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-{2-methyloctan-2- yl)phenol) (also known as CP 47,497 and homologues);
(2) rei-2-[(15,3R)-3-hydroxycyclohexyl]-5-{2-methylnonan-2- yl} phenol {also known as CP 47,497-CS homolog};
(3) [(6aR)-9-{hydroxymethyl}-6,6-dimethyl-3-(2-methyloctan- 2-yl)-6a, 7 10, lOa-tetrahydrobenzo (c] chromen-l-ol)] {also known as HU- 210};
(4) (dexanabinol, (6a5,10a5)-9-(hydroxymethyl)-6,6-dimethyl-3- (2-methyloctan-2-yl)- 6a, 7,10,10a-tetrahydrobenzol[c]chromen-1-ol} {also known as HU-211};
(5) 1-Pentyl-3-{1-naphthoyl) indole {also known as JWH-018};
(6) 1-Butyl-3-{l-naphthoyl) indole {also known as JWH-073};
(7) {2-methyl-l-propyi-1H-indol-3-yl}-lnapthalenyl-methanone {also known as JWH-015};
(8) {l-hexyi-1H-indol-3-yl)-l-naphthalenyl-methanone {also known as JWH-019};
(9) [1-[2-(4-morpholinyl)ethyi]-1H-indol-3-yl]-1-naphthalenyl- methanone {also known as JWH-200};
(10) 1-(1-pentyi-1H-indol-3-yl)-2-(3-hydroxyphenyl)-ethanone {also known asJWH-250};
(11) 2-{{15,2S,5S)-5-hydroxy-2-{3-hydroxtpropyl) cyclohexyl}-5- (2-methyloctan-2-yl)pnenol {also known as CP 55,940};
(12) (4-methyl-1-naphthalenyl)(1-pentyi-1H-indol-3-yl}- methanone {also known as JWH-122};
(13) (4-methyl-1-naphthalenyl)(1-pentyi-1H-indol-3-yl)- methanone {also known as JWH-398;
(14) {4-methoxyphenyO{1-pentyi-1H-indol-3-yl)-methanone {also known as RCS-4};
(15) 1-{1-(2-cyclohexylethyi}-1H-indol-3-yl)-2-(2- methoxyphenyl}jethanone {also known as RCS-8}; and
(Since nomenclature of these substances is not internationally standardized, any immediate precursor or immediate derivative of these substances shall be covered).
(C) Methcathinone,; some other names: (2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methyiamino}-1-phenylpropan-1-one; alpha-– methylaminopropiophenone; monomethylpropion; 3,4-methylenedioxypyrovalerone and/or mephedrone; 3,4-methylenedioxypyrovalerone (MPVD); ephedrone; N-methylcathinone; methylcathinone; AL-464;AL-422; AL-163 and UR1432;
(D) N-benzvlpiperazine, also known as BZP, its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(E) 1-(3-(Trifluoro-methyl)-phenylpiperazine) (TFMPP), its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(F) 4-Bromo-2,5-dimethoxy-l-benzvlpiperazine (2C-B-BZP), its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(G) 2,3-Dichlorophenylpiperazine (DCPP), its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(H) 1,4-Dibenzylpiperazine (DBZP), its immediate precursors and immediate derivatives, its salts, optical isomers ind salts of optical isomers;
(I) 4-Methyl-1-benzylpiperazine (MBZP}, its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(J) 4-lodo-2,5-dimethoxyphenethylamine (2C-I,4-iodo-2,5-DMPEA), its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(K) 4-Methylmethcathinone (mephedrone), its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(L) Dimethylheptvlpyran, its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers;
(M) Kava, also known as Piper methisticum, synthetic equivalents of the substances contained in the plant, or in the resinous extractives, and kavalactones, its immediate derivatives, and its salts, optical isomers and salts of optical isomers;
(N) Khat, also known as Catha edulis, and synthetic equivalents of the substances contained in the plant, or in he resinous extractives;
(O) Kratom, (Mitragyna speciosa korth), synthetic equivalents of the substances contained in the plant, or in the resinous extractives and mitragynine, its immediate derivatives, and its salts, optical isomers and salts of optical isomers.
(P) Hashish and Hash oil, synthetic equivalents of the substances contained in the plant, or in the resinous extractives and mitragynine, its immediate derivatives, and its salt, optical isomers and salts of optical isomers.
(Q) Any analog of any chemicals listed above.
(1) An "Analog" means a substance, the chemical structure of which is substantially similar to the chemical structure of a controlled substance in Schedule I or II:
(a) That has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II of the Federal Drug Scheduling Act or of a substance listed within this section; or
(b) With respect to a particular person, if the person represents or intends that the substance have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II of the Federal Drug Scheduling Act or of a substance listed within this section;
(2) "Analog" does not include:
(a) A controlled substance; or
(b) Any substance for which there is an approved new drug application under the Federal Food, Drug, and "Cosmetic Act; or
(c) With respect to a particular person, any substance, if an exemption is in effect for investigational use, :or that person, as provided by United States Code, Title 21, Section 355, and the person is registered as a controlled substance researcher as required under Section 152.12, Subdivision 3, to the extent conduct with respect to the substance is pursuant to the exemption and registration.
(Ord. 3-2012, passed 4-9-12) Penalty, see § 98.99